Literature DB >> 30473641

Azoospermia With Testosterone Therapy Despite Concomitant Intramuscular Human Chorionic Gonadotropin: NYU Case of the Month, July 2018.

Bobby Najari1.   

Abstract

Entities:  

Year:  2018        PMID： 30473641      PMCID： PMC6241897          DOI： 10.3909/riu0814

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  6 in total

1.  Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men.

Authors: 
Journal:  Fertil Steril       Date:  1996-04       Impact factor: 7.329

2.  Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy.

Authors:  Taylor P Kohn; Matthew R Louis; Stephen M Pickett; Mark C Lindgren; Jaden R Kohn; Alexander W Pastuszak; Larry I Lipshultz
Journal:  Fertil Steril       Date:  2016-11-14       Impact factor: 7.329

3.  Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

Authors:  Shalender Bhasin; Juan P Brito; Glenn R Cunningham; Frances J Hayes; Howard N Hodis; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Frederick C Wu; Maria A Yialamas
Journal:  J Clin Endocrinol Metab       Date:  2018-05-01       Impact factor: 5.958

4.  Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis.

Authors:  Peter Y Liu; Ronald S Swerdloff; Peter D Christenson; David J Handelsman; Christina Wang
Journal:  Lancet       Date:  2006-04-29       Impact factor: 79.321

5.  Evaluation and Management of Testosterone Deficiency: AUA Guideline.

Authors:  John P Mulhall; Landon W Trost; Robert E Brannigan; Emily G Kurtz; J Bruce Redmon; Kelly A Chiles; Deborah J Lightner; Martin M Miner; M Hassan Murad; Christian J Nelson; Elizabeth A Platz; Lakshmi V Ramanathan; Ronald W Lewis
Journal:  J Urol       Date:  2018-03-28       Impact factor: 7.450

6.  Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.

Authors:  Tung-Chin Hsieh; Alexander W Pastuszak; Kathleen Hwang; Larry I Lipshultz
Journal:  J Urol       Date:  2012-12-20       Impact factor: 7.450
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.